跳至主要内容
临床试验/NCT05725122
NCT05725122已完成不适用

Stone Clearance in Patients With Upper Ureteric Stones Using Extracorporeal Shock Wave Lithotripsy Compared With Extracorporeal Shock Wave Lithotripsy Combined With Tamsulosin Therapy

Services Hospital, Lahore1 个研究点 分布在 1 个国家目标入组 82 人开始时间: 2018年2月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
82
试验地点
1
主要终点
stone clearance

研究概览

简要总结

Extracorporeal shock wave lithotripsy (ESWL) is the least invasive and effective treatment for upper ureteric stones with a stone clearance rate of 60-90%. Tamsulosin is an alpha-blocker widely used in urological practice to relax smooth muscle of the prostate and bladder neck. Its role as part of medical expulsion therapy for the treatment of patients with kidney and ureteric stones has proved to be of considerable success. However, its role in clearing upper ureteric stones as an adjunct to ESWL is controversial. Therefore, this study will be conducted to evaluate its role in stone clearance along with extracorporeal shock wave lithotripsy in patients with upper ureteric stones

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • single upper ureteric stone
  • size ranging from 6-15 mm
  • stones history less than 6 months

排除标准

  • Patients with urinary tract infection
  • multiple ureteric stones,
  • presence of a ureteric stricture distal to the stone,
  • previous unsuccessful ESWL,
  • concomitant use of calcium channel blockers or alpha-adrenergic antagonists
  • patients with abnormal coagulation profile

结局指标

主要结局

stone clearance

时间窗: 4 weeks

Number of patients cleared from ureteric stones

次要结局

未报告次要终点

研究者

发起方
Services Hospital, Lahore
申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Dr. SamiUllah

Principal Investigator

Services Hospital, Lahore

研究点 (1)

Loading locations...

相似试验

Stone Clearance in Patients With Upper Ureteric... | 临床试验